scispace - formally typeset
P

Partha Palit

Researcher at Assam University

Publications -  34
Citations -  503

Partha Palit is an academic researcher from Assam University. The author has contributed to research in topics: Leishmania donovani & Medicine. The author has an hindex of 9, co-authored 28 publications receiving 354 citations. Previous affiliations of Partha Palit include Council of Scientific and Industrial Research & Indian Institute of Chemical Biology.

Papers
More filters
Journal ArticleDOI

The urgent need for integrated science to fight COVID-19 pandemic and beyond.

Negar Moradian, +90 more
TL;DR: The importance of bringing the world's scientists together to find effective solutions for controlling the COVID-19 pandemic is discussed, by applying novel research frameworks, interdisciplinary collaboration promises to manage the pandemic’s consequences and prevent recurrences of similar pandemics.
Journal ArticleDOI

Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.

TL;DR: In vitro antibacterial activity of compound 5 against several bacterial strains revealed its promising efficacy and suggested that 1,1-bis-[(5-chloro-8-quinolyl)oxy]methane (5) is a bright candidate to be considered as lead compound for leishmanicidal drug.
Journal ArticleDOI

Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis

TL;DR: Amlodipine and lacidipine, conventional antihypertensive drugs, inhibited Leishmania donovani infection in vitro and in BALB/c mice when administered orally.
Journal ArticleDOI

Oral therapy with sertraline, a selective serotonin reuptake inhibitor, shows activity against Leishmania donovani

TL;DR: A sertraline-induced fall in cytoplasmic ATP levels and oxygen consumption rate in promastigotes suggests the involvement of an apoptosis mode of cell death in the treated parasites.
Journal ArticleDOI

Cationic Liposomal Sodium Stibogluconate (SSG), a Potent Therapeutic Tool for Treatment of Infection by SSG-Sensitive and -Resistant Leishmania donovani

TL;DR: PC-DDAB-SSG could effectively alleviateSSG-sensitive and SSG-resistant L. donovani infections at a dose of SSG not reported previously, attributed to better interactions with the parasite membranes, resulting in direct killing, and generation of a strong host-protective environment.